Oncological and functional outcomes after repeat transoral laser microsurgery for the treatment of recurrent early glottic cancer. Issue 2 (21st February 2020)

• Record Type: Journal Article
• Authors: Forner, D; Rigby, M H; Corsten, M; Trites, J R; Pyne, J; Taylor, S M
• Is Part Of: Journal of laryngology & otology. Volume 134:Issue 2(2020)
• Page Start: 169
• Page End: 173
• Publication Date: 2020-02-21
• Subjects: Laryngeal Neoplasms, -- Microsurgery, -- Voice Quality, -- Lasers, -- Gas; Otolaryngology -- Periodicals; 617.51
• DOI: 10.1017/S0022215120000407
• Languages: English
• ISSNs: 0022-2151

Abstract

Abstract: Background: Transoral laser microsurgery for glottic squamous cell carcinoma is the standard of care at many institutions. Repeat transoral laser microsurgery for recurrence may avoid the need for radiotherapy and total laryngectomy. This study aimed to identify oncological and functional outcomes in a cohort of patients who had undergone repeat transoral laser microsurgery procedures. Method: A retrospective review of prospectively collected data of patients treated with transoral laser microsurgery for carcinoma in situ or tumour stages T1 or T2 glottic cancer, from 2003 to 2018. Results: Twenty patients were identified. Additional treatment was not needed in 45 per cent of patients. The five-year overall survival rate was 90 per cent. The disease-specific survival rate was 100 per cent. The laryngeal preservation rate was 85 per cent. There was improvement in mean Voice Handicap Index-10 scores following repeat transoral laser microsurgery treatment, when comparing the pre- and post-operative periods (mean scores = 15.5 vs 11.5, p = 0.373). Conclusion: Repeat transoral laser microsurgery can be an oncologically safe alternative to other salvage therapies for glottic squamous cell carcinoma recurrence, without sacrificing functional outcomes.